Effectiveness of Artificial Intelligence–Based Platform in Administering Therapies for Children With Autism Spectrum Disorder: 12-Month Observational Study
JMIR Neurotechnology · 2025-04-28 · 4 · e70589-e70589
DOI: 10.2196/70589 ↗At a glance
Journal article in JMIR Neurotechnology, published online on 2025-04-28. Written by Harini Atturu and 2 co-authors. Institution: Psychiatry, CARE Hospitals, Hyderabad, India. Cited 18 times so far (Crossref); 70 references. The full text is freely available in PubMed Central.
Topics: Künstliche Intelligenz in der Pflege, Kinderkrankenpflege
Abstract (original language)
Background
A 12-month longitudinal observational study was conducted on 43 children aged 2‐18 years to evaluate the effectiveness of the CognitiveBotics artificial intelligence (AI)–based platform in conjunction with continuous therapy in improving therapeutic outcomes for children with autism spectrum disorder (ASD).
Objective
This study evaluates the CognitiveBotics software’s effectiveness in supporting children with ASD through structured, technology-assisted learning. The primary objectives include assessing user engagement, tracking progress, and measuring efficacy using standardized clinical assessments.
Methods
A 12-month observational study was conducted on children diagnosed with ASD using the CognitiveBotics AI-based platform. Standardized assessments, include the Childhood Autism Rating Scale (CARS), Vineland Social Maturity Scale, Developmental Screening Test, and Receptive Expressive Emergent Language Test (REEL), were conducted at baseline (T1) and at the endpoint (T2). All participants meeting the inclusion criteria were provided access to the platform and received standard therapy. Participants who consistently adhered to platform use as per the study protocol were classified as the intervention group, while those who did not maintain continuous platform use were designated as the control group. Additionally, caregivers received structured training, including web-based parent teaching sessions, reinforcement strategy training, and home-based activity guidance.
Results
Participants in the intervention group demonstrated statistically significant improvements across multiple scales. CARS scores reduced from 33.41 (SD 1.89) at T1 to 28.34 (SD 3.80) at T2 ( P
Subjects
Author keywords
Authors and institutions
- Psychiatry, CARE Hospitals, Hyderabad, India.
- Department of Psychology, Rainbow Children's Hospital, Hyderabad, India.
- CognitiveBotics Technologies Private Limited, 6th Floor, TSIIC, MYHOME TWITZA, Raidurg, Telangana, Hyderabad, 500081, India, 91 7893855499.
ORCID profiles: Harini Atturu, Somasekhar Naraganti, Bugatha Rajvir Rao
Cite
APA
Atturu, H., Naraganti, S., & Rao, B. R. (2025). Effectiveness of Artificial Intelligence–Based Platform in Administering Therapies for Children With Autism Spectrum Disorder: 12-Month Observational Study. JMIR Neurotechnology, 4, e70589-e70589. https://doi.org/10.2196/70589
Vancouver
Atturu H, Naraganti S, Rao BR. Effectiveness of Artificial Intelligence–Based Platform in Administering Therapies for Children With Autism Spectrum Disorder: 12-Month Observational Study. JMIR Neurotechnology. 2025;4:e70589-e70589. doi:10.2196/70589
BibTeX
@article{Atturu2025,
author = {Atturu, Harini and Naraganti, Somasekhar and Rao, Bugatha Rajvir},
title = {Effectiveness of Artificial Intelligence–Based Platform in Administering Therapies for Children With Autism Spectrum Disorder: 12-Month Observational Study},
journal = {JMIR Neurotechnology},
year = {2025},
volume = {4},
pages = {e70589--e70589},
doi = {10.2196/70589}
}
EUVIMED